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Abstract
Meta-analyses of population-based genome-wide association studies (GWAS) in adults have recently led to the detection of
new genetic loci for obesity. Here we aimed to discover additional obesity loci in extremely obese children and adolescents.
We also investigated if these results generalize by estimating the effects of these obesity loci in adults and in population-
based samples including both children and adults. We jointly analysed two GWAS of 2,258 individuals and followed-up the
best, according to lowest p-values, 44 single nucleotide polymorphisms (SNP) from 21 genomic regions in 3,141 individuals.
After this DISCOVERY step, we explored if the findings derived from the extremely obese children and adolescents (10 SNPs
from 5 genomic regions) generalized to (i) the population level and (ii) to adults by genotyping another 31,182 individuals
(GENERALIZATION step). Apart from previously identified FTO, MC4R, and TMEM18, we detected two new loci for obesity:
one in SDCCAG8 (serologically defined colon cancer antigen 8 gene; p = 1.8561028 in the DISCOVERY step) and one
between TNKS (tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase gene) and MSRA (methionine sulfoxide
reductase A gene; p = 4.8461027), the latter finding being limited to children and adolescents as demonstrated in the
GENERALIZATION step. The odds ratios for early-onset obesity were estimated at ,1.10 per risk allele for both loci.
Interestingly, the TNKS/MSRA locus has recently been found to be associated with adult waist circumference. In summary,
we have completed a meta-analysis of two GWAS which both focus on extremely obese children and adolescents and
replicated our findings in a large followed-up data set. We observed that genetic variants in or near FTO, MC4R, TMEM18,
SDCCAG8, and TNKS/MSRA were robustly associated with early-onset obesity. We conclude that the currently known major
common variants related to obesity overlap to a substantial degree between children and adults.
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Introduction
Recent genome-wide association studies (GWAS) conducted in
adult population-based samples assessed for body mass index
(BMI) or in case-control designs for extreme obesity led to the
discovery of genetic loci relevant for body weight regulation. The
first genetic loci were detected via variants in intron 1 of the FTO
(fat mass and obesity associated gene; e.g., [1–4]) and variants
approx. 200 kb downstream of MC4R (melanocortin 4 receptor
gene; [5–8]) reported by the GIANT (Genetic Investigation of
ANthropometric Traits) consortium. This consortium subsequent-
ly detected six additional genetic loci relevant for BMI in a meta-
analysis of 15 GWAS based on 32,387 probands and large
confirmation samples (.58,000 individuals; with single nucleotide
polymorphisms (SNP) in or near TMEM18, transmembrane
protein 18 gene; KCTD15, potassium channel tetramerization
domain containing 15 gene; GNPDA2, glucosamine-6-phosphate
deaminase 2 gene; SH2B1, SH2B adapter protein 1 gene;
MTCH2, mitochondrial carrier homologue 2 gene; NEGR1,
neuronal growth regulator 1 gene). In parallel, a combined
analysis of 34,416 individuals from Iceland, the Netherlands,
North America (European and African descent) and Scandinavia
revealed 11 regions of genome-wide significance at #1.661027 (in
or near FTO; MC4R; TMEM18; KCTD15; SH2B1; NEGR1;
SEC16B, SEC16 homologue B gene; ETV5, ets variant gene 5;
BDNF, brain-derived neurotrophic factor gene and two gene rich
loci on chromosome 6p21.33 and 12q13.13 with the closest genes
AIF1, allograft inflammatory factor 1 gene, and BCDIN3D,
BCDIN3 domain containing gene, respectively). Finally, shifting
to the analysis of extremely obese subjects, Meyre et al. [9]
analyzed GWAS data from 1,380 Europeans with early-onset and
morbid adult obesity and 1,416 age-matched normal-weight
controls and reported three new risk loci in NPC1 (Niemann-Pick
disease, type C1 gene), near MAF (v-maf musculoaponeurotic
fibrosarcoma oncogene homolog gene) and PTER (phosphotries-
terase related gene), which were followed-up in 14,186 European
subjects. Altogether, 16 genetic loci relevant for body weight
regulation have been identified by these three GWAS approaches
[10–12].
While meta-analytic combinations of multiple GWAS were
highly successful in population-based samples, no such approach
has up to now been applied to case-control designs for obesity.
Here we combined GWAS based on two samples that were
specifically ascertained for the analysis of paediatric extreme
obesity [3,9]. We aimed to identify genetic loci that are relevant
for early onset extreme obesity and to determine effect sizes of
such loci for obesity in adults and in population-based samples
including both children and adults (see Figure 1 for the general
design of the study).
In particular, our study design was based on two steps to enable
hypothesis-free SNP identification and confirmation. In the
DISCOVERY step, we screened 2,239,392 genotyped or imputed
SNPs and tested 1,596,878 SNPs (after quality control) for
association in a combined French and German sample of 1,138
extremely obese children and adolescents and 1,120 normal- or
underweight controls as based on a minor allele frequency above
1%. Next, we (de novo) genotyped all SNPs with strong evidence for
an association to obesity (according to p-value ranking; for details
see ‘‘Materials and Methods’’ and Text S1) in independent
samples of 1,181 obese children and adolescents and 1,960
normal- or underweight controls and in up to 715 nuclear families
with at least one extremely obese offspring. In the GENERAL-
IZATION step, we extended the focus of our study in two
dimensions - (i) from children and adolescents to adults and (ii)
from (extreme) obesity to the population level (in sum we (de novo)
genotyped 31,182 individuals in the GENERALIZATION step).
In addition to our hypothesis-free step-wise design, we aimed to
re-confirm the associations of the recently reported GWAS-based
genetic loci for body weight regulation [9,13,14] in our paediatric
extreme obesity GWAS meta-analysis.
Results
In our GWAS meta-analysis based on the German and French
study groups encompassing both young obese cases and normal
weight or lean controls we discovered three SNPs with genome-
wide significance (Table 1 and Figure 2, Figure S1) even when
applying the conservative Bonferroni correction at aBF<3.161028
for all 1,596,878 SNPs. While two markers are located in the
previously reported FTO (intron 1; rs1421085; p = 2.9961028)
and downstream ofMC4R (rs17700144; p = 2.4061028), rs473034
indicates a new genetic locus for early onset extreme obesity
located on chromosome 8p23.1 (p= 2.7761028) with the closest
genes TNKS (tankyrase, TRF1-interacting, ankyrin-related ADP-
ribose polymerase gene; ,135 kb upstream of rs473034) and
MSRA (methionine sulfoxide reductase A gene; ,178 kb down-
stream of rs473034). In addition to the three genome-wide
significant regions, the GWAS data revealed 18 genomic regions
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of interest which were defined by (i) two-sided p-values of a lead
SNPs #1025 and (ii) more than a single SNP within a locus (lead
SNP6500 kb) showing evidence for association as defined via a p-
value rank ,1,500 (roughly corresponding to p#561024; for
details see Text S1).
As part of our DISCOVERY step, we subsequently (de novo)
genotyped 44 SNPs representing these 21 genomic regions of
interest in independent 1,181 obese children and adolescents and
1,960 normal- or underweight controls and in up to 715 nuclear
families with at least one extremely obese offspring (Table 1; Table
S3). For 5 out of the 21 regions the association was directionally
consistent (i.e. we observed the same obesity risk effect allele as in
our GWAS meta-analysis) and the minimum combined p-value for
each region across the samples was p#561024 (Table 1; for
details see Text S1). These 5 genomic regions included three
known loci on chromosome 2p25.3 (TMEM18), 16q12.2 (FTO),
18q21.32 (39 of MC4R) as well as two new loci on chromosome
1q43-q44 and on chromosome 8p23.1 (Figure 2, Figure S2). The
SNPs of the first new locus on chromosome 1q43-q44 are located
within introns of the SDCCAG8 (serologically defined colon cancer
antigen 8 gene) whereas the second new locus on chromosome
8p23.1 between the TNKS and MSRA had already showed
evidence for an association at the genome-wide level in the initial
paediatric extreme obesity GWAS meta-analysis.
Based on these results, we extended the focus of our study in two
dimensions - from children and adolescents to adults and from the
extremes to the population level - looking for GENERALIZA-
TION of the replicated 5 regions represented by 10 SNPs
(Table 1). Comparing children and adolescents to adults using
case-control designs with overweight and obese cases vs. normal
weight controls revealed directionally consistent (see above)
findings for the variants of FTO, TMEM18 and the novel
SDCCAG8 (Table 1). Similarly the odds ratios for the respective
obesity risk effect alleles did not vary strongly by group (children
and adolescents vs. adults) with point estimates ranging between
1.35–1.45 (FTO), 1.35–1.45 (TMEM18) and 1.10–1.19
(SDCCAG8). For the SNPs related to MC4R and the new TNKS/
MSRA locus, however, we observed age dependent differences: For
MC4R, we confirmed the findings by Loos and co-workers [6] by
finding a stronger effect size estimator in children and adolescents
as compared to adults (1.44 vs. 1.14 for rs17700144 of MC4R;
p = 9.3961023 for the interaction of genotype and group). For
TNKS/MSRA, we found an effect in children and adolescents but
no effect in adults (e.g., 1.12 vs. 0.97 for rs516175). These
differences in obesity risk effects between children and adolescents
as compared to adults, however, were not due to large differences
in allele frequencies as based on the population-based samples
with a maximum difference of 0.82% for rs11127485 of TMEM18.
We then compared (extreme) obesity assessed in case-control
designs to the analyses of quantitative BMI data derived from
population-based samples in the GENERALIZATION step (3,525
children and adolescents and 25,958 adults of European origin;
Table 1, Table 2). BMI analyses revealed that the two SNPs in
FTO and TMEM18 would have also been detectable using
population-based samples of the given sizes from children/
adolescents and adults (p-values 7.8761024 and 9.99610216 for
FTO and 0.01 and 9.97610212 for TMEM18 with the values in
the adults being even significant at a stringent genome-wide
significance level of a=561028). The MC4R SNP, however,
would have been harder to detect (p-values of 0.02 for children
and adolescents and 1.1061024 for adults); detection of the two
Figure 1. Study design to discover consistently associated genetic loci for (early-onset) obesity. In the DISCOVERY step we jointly
analysed two GWAS focussing on extremely obese children and adolescents. Markers with the smallest p-values of the GWAS were validated in
independent case-control and nuclear family samples again with a focus on overweight/obese children and adolescents. Afterwards, in the
GENERALIZATION step, we extended the focus in two dimensions—(i) from the extremes to the population level and (ii) from children and
adolescents to adults. Note that we used controls selected from the population-based samples for the cases-control comparison with obese
individuals for the GENERALIZATION (BMI quartile , median for children & BMI ,25 kg/m2 for adults).
doi:10.1371/journal.pgen.1000916.g001
Author Summary
Genome-wide association studies (GWAS) have successful-
ly contributed to the detection of genetic variants involved
in body-weight regulation. We jointly analysed two GWAS
for early-onset extreme obesity in 2,258 individuals of
European origin and followed-up the findings in 3,141
individuals. Evidence for association of markers in two new
genetic loci was shown (SDCCAG8 on chromosome 1q43–
q44 and between TNKS/MSRA on chromosome 8p23.1). We
also re-identified variants in or near FTO, MC4R, and
TMEM18 to be associated with extreme obesity. In
addition, we assessed the effect of the markers in 31,182
obese, lean, normal weight, and unselected individuals
from population-based samples and showed that the
variants near FTO, MC4R, TMEM18, and SDCCAG8 were
consistently associated with obesity. For variants of TNKS/
MSRA, the obesity association was limited to children and
adolescents. In summary, we detected two new obesity
loci and confirmed that the currently known major
common variants related to obesity overlap to a substan-
tial degree between children and adults.
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new loci SDCCAG8 and TNKS/MSRA would have been impossible
(Table 2).
In sum, our hypothesis-free step-wise design revealed three
known (FTO, MC4R and TMEM18) and two new loci (SDCCAG8
and TNKS/MSRA) with estimated odds ratios that ranged from
,1.07 to ,1.44 in children and adolescents and from ,1.17 to
,1.45 in adults with the strongest overall signals related to the
FTO locus. Modelling of the joint and epistatic effects revealed that
,1% of the BMI (or BMI-SDS when BMI is expressed as
standard deviation score) variance can be attributed to the five
variants analyzed in or near TNKS/MSRA, SDCCAG8, TMEM18,
FTO, and MC4R. For children and adolescents this value did not
change upon inclusion of gender, age and age2 as covariates
whereas it changed to 11% for the adult sample (KORA S2-S4).
Applying the model including the same covariates derived in one
population-based data set of adults (KORA S2-S4) to a second
population-based data sets of adults (Heinz-Nixdorf Recall Study)
r2 dropped from 11% to ,2%. Proceeding similarly for epistatic
effects, we found no evidence for strong epistatic effects using
regression tree analyses (Figure S3, Figure S4).
In addition to our hypothesis-free step-wise design, we
investigated our paediatric extreme obesity GWAS meta-analysis
data focussing on recently reported GWAS-based candidate
markers [9,13,14]. For the 16 confirmed genetic loci for which
quality controlled genotyped or imputed SNPs were available, two
loci on chromosome 1 (1p31.1–NEGR1, 1q25.2 - SEC16B), a locus
on 11p14.1 near BDNF, and a gene-rich locus on 12q13.13 near
BCDIN3D all showed directionally consistent effects of the
respective SNPs (all p#.005). Details on all analysed candidate
gene SNPs are provided in Table S4 and Table S5. Note that the
16 confirmed genetic loci [9,13,14] correspond to 46 SNPs in our
GWAS meta-analysis; in case of multiple markers at the same
locus all showed evidence for strong LD (r2..9).
Discussion
We identified two new genomic loci associated with paediatric
obesity on chromosomes 1q43–q44 and 8p23.1 by a meta-analysis
of two GWAS for early onset extreme obesity with a total 2,258
individuals of European origin. In addition, we confirmed the
three known loci FTO, MC4R and TMEM18 using a hypothesis-
free step-wise design. Leaving the hypothesis-free approach and
focussing on known GWAS-based candidate markers, we were
able to substantiate another four loci (NEGR1, SEC16B, BDNF and
BCDIN3D) of the 16 obesity loci previously detected in GWAS
[6,9,13,14]. Thus, we demonstrate that the currently known major
common variants related to obesity overlap to a substantial degree
between children and adults confirming previous observations for
FTO, MC4R, TMEM18, NEGR1 [2,6,14] and extending this
observation to SEC16B, BDNF and BCDIN3D; [13,14]. As our
meta-analysis includes data from Meyre et al. [9] an independent
well-powered replication of NPC1, MAF and PTER was not
possible here.
The new chromosome 1q43–q44 locus was represented by three
SNPs in strong pairwise LD (r2..9) which are located in introns 6,
9 and 10 of SDCCAG8. There is no obvious indication for an
involvement of SDCCAG8 in body weight regulation. Data on this
gene are scarce. It has been shown that SDCCAG8 is located in
centrosomes during interphase and mitosis in human and murine
cells. N- and C- terminal truncations of the human protein alter
this location; a possible role of SDCCAG8 (alternative name: NY-
CO-8) in centrosomal organization has been suggested [15]. It is
considered to be a naturally occurring autoantigen [16]. SDCCAG8
is ubiquitously expressed, amongst other tissues in thymus, small
intestine, colon mucosa, liver and brain (http://www.genecards.
org/cgi-bin/carddisp.pl?gene = SDCCAG8). Hypothalamus, pitu-
itary and adrenals have been shown to have a particularly high
transcript abundance. This pattern indicates a role of SDCCAG8
in this pivotal hormonal axis that is well-known for its impact on
body weight regulation [16]. Other candidate genes in proximity
of the three SNPs include CEP170 (centrosomal protein 170 kDa
gene, ,95 kb downstream of rs12145833) and AKT3 (v-akt
murine thymoma viral oncogene homolog 3 (protein kinase B,
gamma) gene, ,168 kb upstream of rs12145833) with the latter
being the more interesting candidate. The protein encoded by this
gene is a member of the AKT family known to regulate cell
signalling in response to insulin and growth factors. In particular
AS160, an Akt substrate of 160 kDa, and TBC1D1 (TBC1
domain family, member 1) have been suggested to have
complementary roles in regulating vesicle trafficking in response
to insulin [17] with TBC1D1 being persuasively linked to body
weight regulation [18–20]. However, we observed no evidence for
strong pairwise LD (r2..9) to any likely functional relevant variant
in a region of 61 Mb around the lead SNP (rs12145833) using
Ensembl (version 56; GRCh37, 02/2009; Figure S6).
Figure 2. Results of the meta-analysis of two genome-wide association studies for early-onset extreme obesity. SNPs are plotted on
the x-axis according to their position on each chromosome (HapMap, release 22) against the association signal on the y-axis (shown as -log10 of the
two-sided (deflated/adjusted) p-value). SNPs genotyped in the independent samples of the DISCOVERY step are shown as blue circles (some of them
are proxy SNPs of the best signals). SNPs followed-up in the GENERALIZATION step as well are shown as orange squares. For details on the marker
selection see Text S1.
doi:10.1371/journal.pgen.1000916.g002
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Table 2. GENERALIZATION.
GENERALIZATION
children and adolescents (n=3,525) adults (n =25,958)
chromosomal
regiona (sug-
gested gene)
SNP (obesity
risk effect
alleleb)
BMI-SDSd estimator
(beta) for effect
allele (95% CI) p-value
BMI estimator (beta)
for effect allele
(95% CI) p-value
combined BMI
estimator (beta) for
effect allele (95% CI)e
combined
p-valuee
1q43–q44 (SDCCAG8) rs10926984 (T) 0.016 (20.043;0.076) 0.59 K 0.04 (20.11;0.19) 0.57 0.02 (20.10; 0.13) 0.79
E 0.01 (20.22;0.25) 0.91
H 20.05 (20.31;0.21) 0.73
rs12145833 (T) 20.008 (20.067;0.050) 0.78 K 0.07 (20.08;0.22) 0.39 0.05 (20.05;0.16) 0.33
S 0.18 (20.09;0.44) 0.20
E 0.01 (20.22;0.25) 0.92
H 20.07 (20.33;0.19) 0.60
rs2783963 (C) 0.006 (20.054;0.066) 0.85 K 0.03 (20.12;0.18) 0.70 0.02 (20.10;0.13) 0.79
E 0.01 (20.23;0.25) 0.94
H 20.02 (20.28;0.24) 0.90
2p25.3 (TMEM18) rs11127485 (T) 0.079 (20.021;0.136) 0.01 K 0.37 (0.22;0.52) 9.2661027 0.35 (0.25;0.45) 9.97610212
S 0.46 (0.20;0.72) 0.001
E 0.19 (20.04;0.42) 0.11
H 0.38 (0.14;0.63) 0.002
8p23.1 (TNKS/MSRA) rs17150703 (A) 20.028 (20.103;0.047) 0.46 K 20.12 (20.31;20.06) 0.19 20.10 (20.23;0.03) 0.12
S 20.16 (20.49;0.18) 0.37
E 0.01 (20.28;0.31) 0.93
H 20.13 (20.44;0.19) 0.43
rs13278851 (A) 20.022 (20.096;0.052) 0.56 K 20.13 (20.31;0.06) 0.18 20.10 (20.24;0.04) 0.15
E 0.00 (20.30;0.30) 0.99
H 20.13 (20.44;0.19) 0.44
rs516175 (T) 20.004 (20.073;0.064) 0.90 K 20.03 (20.20;0.15) 0.76 20.04 (20.16;0.08) 0.49
S 20.13 (20.45;0.19) 0.42
E 0.00 (20.29;0.26) 0.99
H 20.05 (20.35;0.26) 0.77
16q12.2 (FTO) rs1558902 (A) 0.074 (0.031;0.116) 7.8761024 K 0.29 (0.18;0.40) 1.3461027 0.31 (0.24;0.39) 9.99610216
S 0.19 (20.01;0.39) 0.07
E 0.44 (0.27;0.61) 4.6961027
H 0.34 (0.14;0.53) 7.7661024
rs9935401 (A) 0.074 (0.030;0.117) 9.0461024 K 0.29 (0.18;0.40) 3.3561027 0.30 (0.23;0.38) 7.99610215
S 0.17 (20.02;0.37) 0.09
E 0.44 (0.26;0.60) 1.3661026
H 0.33 (0.13;0.53) 0.001
18q21.32 (MC4R) rs17700144 (A) 0.064 (0.011;0.116) 0.02 K 0.10 (20.03;0.23) 0.13 0.17 (0.08;0.26) 1.1061024
S 0.28 (0.05;0.51) 0.02
E 0.18 (20.02;0.39) 0.08
H 0.27 (0.04;0.50) 0.02
Evidence for quantitative associations (BMI or standard deviation score of BMI (BMI-SDS)) assessed cross-sectionally for 5 loci (10 SNPs) under an additive genetic model.
Effect sizes as point estimators and 95% confidence intervals (95% CI), p-values (two-sided) and combined effect estimators and p-values are presented for the adults
with abbreviations for the samples: KORA, SHIPc, EPIC-Potsdam, Heinz-Nixdorf Recall Study; all samples are described in detail in Text S1.
aposition and stranding according to dbSNP BUILD 129; Map to Genome Build 36.3;
b(obesity) effect risk alleles as derived from the paediatric extreme obesity GWAS meta-analysis;
cresults for SHIP are based on in silico GWAS data–proxy markers (FTO: rs8050136 for rs9935401, rs1421085 for rs1558902; MC4R: rs476828 for rs17700144); one marker
for each region was regarded as sufficient if the others were not available;
dBMI-SDS is a normalized version of BMI expressed as standard deviation score that includes information on age and gender; the results were similar if age and gender
were included as covariates;
eby inverse normal method (function metagen in the package meta of R) with weights proportional to the sample size (fixed effects model).
doi:10.1371/journal.pgen.1000916.t002
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The new chromosome 8p23.1 locus, for which we observed
genome-wide significance in our GWAS meta-analysis (Figure 1,
Figure S2), was also represented by three SNPs with strong
pairwise LD (r2..9). TNKS andMSRA are the genes located closest
to our association finding. MSRA encodes a repair enzyme for
oxidative damage in proteins by enzymatic reduction of
methionine sulfoxide. Oxidation of methionine residues in proteins
is considered to be an important consequence of oxidative damage
to cells [21]. Oxidation of proteins by reactive oxygen species
(ROS) is generally associated with oxidative stress, aging and many
neurodegenerative diseases such as Alzheimer’s disease [21]. Also,
obesity is associated with oxidative stress in the mitochondrion,
with the chronic excess of ROS resulting in mitochondrial
dysfunction in liver and skeletal muscle contributing to insulin
resistance [22]. MSRA is mainly expressed in kidney followed by
liver, brain, and adipose tissue (http://biogps.gnf.org/#goto =
genereport&id = 4482). The other candidate gene at the chromo-
some 8p23.1 locus is TNKS which is ubiquitously expressed
(http://biogps.gnf.org/#goto= genereport&id = 8658). Tankyr-
ase is a Golgi-associated poly-ADP-ribose polymerase, which is
involved in the regulation of GLUT4 trafficking in 3T3-L1
adipocytes. Mice lacking Tnks show increased energy expenditure,
fatty-acid oxidation, and insulin-stimulated glucose utilization;
they are lean even with excessive food intake [23]. In other
GWAS, the 8p23.1 genomic region has been related to increased
triglyceride levels [24] and to waist circumference in adults [21].
The variants with the strongest reported association signals
(rs7819412; rs7826222 which is now labelled rs545854) are about
1.3 and .08 Mb downstream of our best finding (rs473034). For
the former, the association to obesity was moderate in our GWAS
meta-analysis data (p = 0.02) whereas for the latter no genotype
data were available (with pairwise LD between rs545854 and
rs473034 of r2,.01 (D’ = .03) according to Ensembl version 56).
Thus, further research is needed to elucidate if our finding for
TNKS/MSRA detected in paediatric extremes of the quantitative
trait BMI and the finding for waist circumference in adults [21]
point to the same underlying genetic mechanism.
In our study we used two steps to enable hypothesis-free SNP
identification and confirmation covering the extremes and the
population distribution of BMI in paediatric as well as adult
samples. Both dimensions of our design are related to statistical
power considerations and the genetic architecture of the
phenotype studied. A case-control design with highly selected
individuals outperforms a design using unselected population-
based individuals if the same number of individuals are
genotyped and if the same alternative hypothesis holds true (see
Text S1). This contrast will be aggravated the more extreme the
selection and possibly also the younger the subjects [25]. In
addition the selection of extremes may lead to the detection of
genetic variations that are rare in the population, that
accumulated in families and that might result in stronger effect
sizes. Nevertheless, the power of our GWAS meta-analysis sample
is still limited for small effects (see Text S1) and growing consortia
like GIANT [14] will be best suited to detect them. Not
surprisingly, we confirmed the strongest effects (odds ratio for the
obesity risk effect alleles of ,1.4) reported for children and
adolescents near FTO, MC4R and TMEM18 [12] but also found
support for variants near NEGR1, SEC16B, BDNF and BCDIN3D.
Thus, one may speculate, that the genetic architecture in the
paediatric extremely obese is in part similar to the BMI findings
based mainly on adults from large population-based assessments
(e.g. [13,14]). On the other hand, some of the related effect sizes
of these variants seem to vary longitudinally as shown here for
MC4R and previously stressed by others [6,26] while other
genetic loci might only be relevant for (paediatric) extreme obe-
sity such as TNKS/MSRA.
In conclusion, two new loci related to body weight regulation
were identified using highly selected paediatric samples from the
extremes of the quantitative phenotype BMI. By showing that one
locus is relevant across all age groups whereas the impact of a
second is limited to childhood and adolescence, our data support
previous studies showing the importance of age-related aspects
upon interpretation of GWAS signals.
Materials and Methods
Study samples, genotyping, and quality control
Our study design consisted of two steps (Figure 1). As first part
of the DISCOVERY step we performed a meta-analysis of two
genome-wide association studies (GWAS) including 1,370 indi-
viduals of French and 888 of German ancestry, defined by self-
reported ethnicity. Ascertainment in both GWAS was very similar
with a focus on extremely obese children and adolescents and
normal weight or lean controls (Table S1). Body-mass-index (BMI
in kg/m2) was calculated and the extremes were defined using
percentile criteria of large population-based samples of the general
population [27,28]. We applied the cut-offs $97th percentile and
$90th percentile to define ‘obesity’ and ‘overweight’ in children
and adolescents; most of the cases with extreme obesity had a BMI
$99th percentile (Table S1; [29]). Whole-genome genotyping was
carried out using the Illumina Human CNV370-Duo array
(French GWAS) and the Affymetrix Genome-Wide Human SNP
Array 6.0 (German GWAS). Genotype data quality measures, e.g.
genotype calling rates, were similar in both GWAS (Table S2). To
combine both datasets, the GWAS genotypes were imputed using
publicly available HapMap CEU (release 22; http://www.
hapmap.org). From this GWAS meta-analysis, we selected 44
SNPs covering 21 loci (Table S3; Figure S5) which we (de novo)
genotyped in 1,181 overweight and obese children and adolescents
and 1,960 normal weight or lean children and adolescents and
young adults (controls) of European ancestry and up to 715
nuclear families with obese offspring of European ancestry were
examined. The SNP selection was based on (i) an unadjusted two-
sided p-values #1025 and (ii) more than a single SNP within a
locus (lead SNP 6500 kb) showing evidence for association (with a
p-value rank ,1,500 roughly corresponding to p#561024; for
details see Text S1). Sub-whole genome SNP genotyping was
performed using by the MALDI-TOF mass spectrometry-based
iPLEX Gold assay. In the GENERALIZATION step, 10 SNPs,
for which DISCOVERY step had revealed consistent observations
(Table 1; Table 2), were further investigated for generalizability to
adults and to unselected population-based samples. Thus, 711
overweight and obese children and adolescents (Datteln Paediatric
Obesity sample), 3,525 children and adolescents from the general
population (GINI, LISA, Berlin School Girls), 988 obese adults
(Marburg Adult Obesity sample) and 25,958 adults from the
general population (EPIC-Potsdam Study, KORA S2-S4, SHIP,
Heinz-Nixdorf Recall Study) each of European ancestry were
genotyped. SNP genotyping was performed by the MALDI-TOF
mass spectrometry-based iPLEX Gold assay at the Helmholtz
Zentrum, Mu¨nchen and at the Department of Genomics, Life &
Brain Center, Bonn or by KBioscience, Hoddeston, UK. All were
assessed for genotype calling rates and deviations from Hardy–
Weinberg equilibrium (for details see Text S1).
The RefSeq accession numbers for the reported genes are: FTO:
NM_001080432; MC4R: NM_005912; TNKS: NM_003747;
SDCCAG8: NM_006642.2; TMEM18: NM_152834; CEP170:
NM_014812; AKT3: NM_181690.
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Statistical analysis
After similar quality control analyses of both GWAS, the
imputed GWAS were jointly analysed using the inverse normal
method to combine p-values of allele-based chi-square tests.
Details on the imputation and on the marker selection for the
follow-up are described in Text S1. In the paediatric extreme
obesity GWAS meta-analysis data set we also explored genetic
variants for obesity recently derived from other GWAS [9,13,14]
and variants for ‘classical’ obesity candidate genes [3,30] by testing
the best SNP reported in Scuteri et al. [4].
In both the DISCOVERY and the GENERALIZATION part of
the study either log-additive or additive genetic models were
applied. Case-control samples were analysed using logistic regres-
sion (both with and without gender and age as covariates). The
nuclear families were analysed using UNPHASED (Version 3.0.13;
[31]) which addresses the correlation among sibs and provides
estimators; nuclear family data and case-control data sets were
combined using a method described in [32]. In the GENERAL-
IZATION step, BMI in adults of population-based samples was
analysed using linear regression with gender and age as covariates.
Similarly, we used linear regression analyses for the population-
based samples of children and adolescents. However, as phenotype
we used a normalized version of the BMI applying Cole’s least mean
square method [33] to express BMI as a standard deviation score
(BMI-SDS) which is comparable to the BMI z-score as e.g. used by
the Center for Disease Control and Prevention (http://www.cdc.
gov/). As BMI-SDS already includes information on gender and
age additional sensitivity analyses were performed where these
covariates were omitted. Note that the case-control analyses in
GENERALIZATION step are not completely independent from
the population-based analyses. In particular, controls in GENER-
ALIZATION were individuals from the population-based samples
which either had a BMI,25 for adults or a BMI percentile below
the median. Due to the similarity to the original design it was
nevertheless decided to report both analyses.
As secondary sensitivity analyses, we performed gender stratified
analyses in all GENERALIZATION samples for the markers
which we followed-up. We explored the recessive and dominant
genetic model, investigated the impact of the control group cut-off
for the case-control analyses (results not shown as they did not alter
the conclusions drawn here) and explored joint and epistatic effects
(multiple linear regression and regression trees using lm, rlm, and
party of R.2.9.1) of all five loci (see Figure S3, Figure S4). To
address, to some extent, problems of the ‘bias-variance trade-off’
and the ‘winners curse’ [34], the largest GENERALIZATION
population-based sample KORA (n= 12,002) was chosen for this
modelling. The model was tested in the Heinz-Nixdorf Recall
Study sample (n = 4,646). These two samples were chosen due to
their largest similarities in the recruitment and due to the
availability of directly genotyped SNPs. In addition, we also
explored the sample of population-based children and adolescents
(GINI, LISA, Berlin School Girls; n = 3,525) separately.
Unless otherwise stated, all reported p-values are nominal, two-
sided and not adjusted for multiple testing. To address multiple
testing in the paediatric extreme obesity GWAS meta-analysis we
applied a Bonferroni-corrected aBF<3.161028 to the quality
controlled SNPs on autosomes. Confidence intervals were calculat-
ed with coverage of 95% (abbreviated 95%CI). More details on
quality control and power considerations are provided in Text S1.
Ethics statement
The study, including the protocols for subject recruitment and
assessment, the informed consent for participants, were reviewed
and approved by all local IRB boards.
Supporting Information
Figure S1 DISCOVERY: Quantile-quantile plot of SNPs of the
GWAS meta-analysis focussing on extremely obese children and
adolescents joint analysis (grey unadjusted; black adjusted results -
for details on the adjustment see Text S1). The deviation from the
45-degree-line is due to the presence of multiple truly associated
markers, the ascertainment of the study samples and in part due to
the strategy of the combination for C/G or A/T SNPs.
Found at: doi:10.1371/journal.pgen.1000916.s001 (4.19 MB TIF)
Figure S2 Regional plots of two new loci associated with
obesity. The SNPs are plotted on the x-axis according to their
position on each chromosome (HapMap, release 22) against the
meta-analysis association signal on the y-axis (shown as -log10 of
the two-sided p-value). The plots were generated using SNAP
([24] of Text S1).
Found at: doi:10.1371/journal.pgen.1000916.s002 (8.26 MB TIF)
Figure S3 GENERALIZATION: Regression trees to explore
epistatic effects of validated markers in two independent
population-based samples of adults (left: KORA; right: Heinz-
Nixdorf Recall Study; see main text and Text S1 for details). Only
the five loci of main paper were modelled. Splits in the branches of
the tree indicate different risk classes starting with the strongest
predictor. Here the samples are first split by FTO genotype and
then by TMEM18 genotype. Here we observe some weak evidence
for a marker by marker interaction as the sub-branching in the
FTO genotype branches is not the same for both branches.
Found at: doi:10.1371/journal.pgen.1000916.s003 (9.26 MB TIF)
Figure S4 GENERALIZATION: Regression trees to explore
epistatic effects of validated markers in one population-based
sample of children and adolescents (GINI, LISA, Berlin School
Girls; left: modelling of the five loci only; right: modelling of the
five loci plus sex, age and age 2; see main text and Text S1 for
details). Splits in the branches of the tree indicate different risk
classes starting with the strongest predictor. Here the samples are
first split by FTO genotype and then by MC4R genotype.
However, as shown on the right panel, if age (regression tree
based cut-off at 13.19 years) is included only the FTO genotype
remains as predictor.
Found at: doi:10.1371/journal.pgen.1000916.s004 (9.42 MB TIF)
Figure S5 DISCOVERY: 21 regions of interest from the meta-
analysis of two genome-wide association studies for early onset
extreme obesity. Displayed are the number of SNPs per region for
all 213 SNPs with an unadjusted two-sided p-values #1025 (see
Text S1 for details).
Found at: doi:10.1371/journal.pgen.1000916.s005 (4.19 MB TIF)
Figure S6 Regional plots of the new chromosome 1q43–q44
locus located in SDCCAG8. All variants of Ensembl (version 56;
GRCh37, 02/2009) in a region of 6 1Mb around the lead SNP
(rs12145833) are displayed. The x-axis displays the chromosomal
position of the variant whereas the y-axis indicates LD (r2) of that
variant with rs12145833; the different colours code for different
variant classes (see legend). The plots were generated using
CandiSNPer ([25] of Text S1).
Found at: doi:10.1371/journal.pgen.1000916.s006 (5.52 MB TIF)
Table S1 DISCOVERY: Description of samples that were
jointly analysed in our genome-wide association analysis.
Found at: doi:10.1371/journal.pgen.1000916.s007 (0.05 MB
DOC)
Table S2 DISCOVERY: Genotype data for both GWAS in
extreme early onset obesity.
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Found at: doi:10.1371/journal.pgen.1000916.s008 (0.04 MB
DOC)
Table S3 DISCOVERY: Evidence from obese children and
adolescents (n = 1,181) versus controls (n = 1,960) and 715 nuclear
families with obese offspring. All these samples were not part of the
meta-analysis of two GWAS for early onset extreme obesity.
Found at: doi:10.1371/journal.pgen.1000916.s009 (0.20 MB
DOC)
Table S4 DISCOVERY: GWAS-based SNPs of previously
reported candidate markers for BMI and/or obesity sorted by
chromosome and physical position. The first two columns indicate
the name of a previously identified marker and the implied,
described candidate genes (in bold those which were confirmed
and which are reported in the introduction of the main text). The
columns 6–11 summarize the data of three recently published
large-scale GWAS (Willer et al., 2009 (publication ‘‘WI’’ and
‘‘WI.b’’ for the Appendix of ‘‘WI.b’’), Thorleifsson et al., 2009
(publication ‘‘TH’’), and Meyre et al., 2009 (publication ‘‘ME’’)).
Note that parts of the data sets in Meyre et al. (2009) overlap with
our meta-analyses data set. The table displays the phenotype,
obesity risk effect allele, the frequency of the effect allele, the
estimated additive effect and the related nominal p-value are
derived from publicly available resources. The effect is displayed
using the measurement regarded most appropriate for the design
of the GWAS. The remaining columns correspond to the
respective results observed GWAS meta-analysis.
Found at: doi:10.1371/journal.pgen.1000916.s010 (0.54 MB
DOC)
Table S5 DISCOVERY: SNPs of previously identified ‘classical’
obesity candidate genes. The first column indicates the name of a
previously identified candidate gene. The second column indicates
SNPs which showed strongest association in Scuteri et al. (2007)
for the phenotype, effect allele, frequency, the estimated additive
effect and the related nominal p-value in columns 6–9. The
remaining columns correspond to the respective results observed
in our GWAS meta-analysis (only markers with two-sided adjusted
p-values ,.1 and the ‘directionally consistent’ obesity risk effect
allele are displayed).
Found at: doi:10.1371/journal.pgen.1000916.s011 (0.07 MB
DOC)
Text S1 DISCOVERY and GENERALIZATION.
Found at: doi:10.1371/journal.pgen.1000916.s012 (0.27 MB
DOC)
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